Discogenic Pain
17
3
3
6
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.8%
2 terminated out of 17 trials
75.0%
-11.5% vs benchmark
12%
2 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (17)
Neurodynamic Moblization Versus Mulligan on Pain and Functional Abilities in Patients With Chronic Discogenic Sciatica
VIA Disc NP Registry 3.0
Study Investigating STA363 Compared to Placebo in Patients With Chronic Discogenic Low Back Pain
Evaluation of Efficacy and Safety of Intradiscal Gelified Ethanol in Refractory Cervical Discogenic Pain
Burst Neurostimulation for Discogenic Low Back Pain
Bone Marrow Concentrate Intradiscal Injection for Chronic Discogenic Low Back Pain
VIA Disc NP Registry
TORNADO-Omics Techniques and Neural Networks for the Development of Predictive Risk Models
Identification of Biomarkers and Molecular Targets Involved on Intervertebral Disc Degeneration and Discogenic Pain
Intradiscal Platelet Rich Plasma
Discure Technologies Feasibility Study for DDD
Application of 3D Printing Guide Plate in Percutaneous Disc Decompression
Intervertebral DXM Gel Injection in Adults With Painful Lumbar Degenerative Disc Disease
Safety and Efficacy of PRP for Treatment of Disc Pain
Platelet-rich Plasma for Low Back Pain
Value of Functional Anesthetic and Provocative Discography in the Surgical Treatment of Discogenic Pain
Large Array EMG Discriminability in Discogenic Low Back Pain